Nutritional Supplements and Lipedema: Scientific and Rational Use
Abstract
:1. Introduction
2. Nutritional Supplements
3. Vitamin C
4. Polyphenols
5. Omega 3 Fatty Acids
6. Oedema Modulating Agents
6.1. Serratiopeptidase
6.2. Bromelain
7. Miscellaneous
7.1. Vitamin D
7.2. Vitamin B12
7.3. Magnesium
7.4. Selenium
7.5. Butcher’s Broom
8. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Allen, E.V.; Hines, E.A.J. Lipedema of the legs: A syndrome characterised by fat legs and orthostatic edema. Proc. Staff Meet. Mayo Clin. 1940, 15, 184–187. [Google Scholar]
- Katzer, K.; Hill, J.L.; McIver, K.B.; Foster, M.T. Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation. Int. J. Mol. Sci. 2021, 22, 11720. [Google Scholar] [CrossRef]
- Felmerer, G.; Stylianaki, A.; Hägerling, R.; Wang, A.; Ströbel, P.; Hollmén, M.; Lindenblatt, N.; Gousopoulos, E. Adipose Tissue Hypertrophy, An Aberrant Biochemical Profile and Distinct Gene Expression in Lipedema. J. Surg. Res. 2020, 253, 294–303. [Google Scholar] [CrossRef] [PubMed]
- Paolacci, S.; Precone, V.; Acquaviva, F.; Chiurazzi, P.; Fulcheri, E.; Pinelli, M.; Buffelli, F.; Michelini, S.; Herbst, K.L.; Unfer, V.; et al. GeneOb Project Genetics of lipedema: New perspectives on genetic research and molecular diagnoses. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 5581–5594. [Google Scholar]
- Ishaq, M.; Bandara, N.; Morgan, S.; Nowell, C.; Mehdi, A.M.; Lyu, R.; McCarthy, D.; Anderson, D.; Creek, D.J.; Achen, M.G.; et al. Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema. Int. J. Obes. 2022, 46, 502–514. [Google Scholar] [CrossRef]
- Aksoy, H.; Karadag, A.S.; Wollina, U. Cause and management of lipedema-associated pain. Dermatol. Ther. 2021, 34, e14364. [Google Scholar] [CrossRef]
- Dietary Supplements Market by Type….Global Forecast to 2026. Available online: https://www.marketsandmarkets.com/Market-Reports/dietary-supplements-market (accessed on 30 May 2022).
- Russo, R.; Gallelli, L.; Cannataro, R.; Perri, M.; Calignano, A.; Citraro, R.; Russo, E.; Gareri, P.; Corsonello, A.; Sarro, G.D. When Nutraceuticals Reinforce Drugs Side Effects: A Case Report. Curr. Drug Saf. 2016, 11, 264–266. [Google Scholar] [CrossRef]
- Holmannová, D.; Koláčková, M.; Krejsek, J. Fyziologická úloha vitaminu C ve vztahu ke složkám imunitního systému [Vitamin C and its physiological role with respect to the components of the immune system]. Vnitr. Lek. 2012, 58, 743–749. [Google Scholar] [PubMed]
- Barnes, M.J.; Kodicek, E. Biological hydroxylations and ascorbic acid with special regard to collagen metabolism. Vitam. Horm. 1972, 30, 1–43. [Google Scholar]
- Ronchetti, I.P.; Quaglino, D., Jr.; Bergamini, G. Ascorbic acid and connective tissue. Sub-Cell. Biochem. 1996, 25, 249–264. [Google Scholar]
- Bai, A.; Abdullah, F.; Kumar, J.; Lal, A.; Abbas, M.; Sandesh, R.; Naz, S.; Shahid, S.; Anees, F.; Memon, S. The Role of Vitamin C in Reducing Pain Associated With Diabetic Neuropathy. Cureus 2021, 13, e15895. [Google Scholar] [CrossRef] [PubMed]
- Cannataro, R.; Michelini, S.; Ricolfi, L.; Caroleo, M.C.; Gallelli, L.; De Sarro, G.; Onorato, A.; Cione, E. Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up. Life 2021, 11, 1402. [Google Scholar] [CrossRef]
- Cione, E.; La Torre, C.; Cannataro, R.; Caroleo, M.C.; Plastina, P.; Gallelli, L. Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation. Molecules 2019, 25, 63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Choi, M.-C.; Jo, J.; Park, J.; Kang, H.K.; Park, Y. NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction. Cells 2019, 8, 734. [Google Scholar] [CrossRef] [PubMed]
- Cannataro, R.; Fazio, A.; La Torre, C.; Caroleo, M.C.; Cione, E. Polyphenols in the Mediterranean Diet: From Dietary Sources to microRNA Modulation. Antioxidants 2021, 10, 328. [Google Scholar] [CrossRef]
- Ahamad, J.; Toufeeq, I.; Khan, M.A.; Ameen, M.; Anwer, E.T.; Uthirapathy, S.; Mir, S.R.; Ahmad, J. Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome. Phytother. Res. PTR 2019, 33, 3112–3128. [Google Scholar] [CrossRef]
- Li, F.; Song, Z.; Bo, L.C.; Lyu, L.; Chen, J. Protective effect of Nrf2 activation by curcumin against lead-induced toxicity and apoptosis in SH-SY5Y cells. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2016, 34, 401–405. [Google Scholar] [CrossRef]
- Coletro, H.N.; Diniz, A.P.; Guimarães, N.S.; Carraro, J.; Mendonça, R.D.; Meireles, A.L. Polyphenols for improvement of inflammation and symptoms in rheumatic diseases: Systematic review. Sao Paulo Med. J. = Rev. Paul. De Med. 2021, 139, 615–623. [Google Scholar] [CrossRef]
- Mihanfar, A.; Nouri, M.; Roshangar, L.; Khadem-Ansari, M.H. Polyphenols: Natural compounds with promising potential in treating polycystic ovary syndrome. Reprod. Biol. 2021, 21, 100500. [Google Scholar] [CrossRef]
- Maity, S.; Wairkar, S. Dietary polyphenols for management of rheumatoid arthritis: Pharmacotherapy and novel delivery systems. Phytother. Res. 2022, 36, 2324–2341. [Google Scholar] [CrossRef]
- Calder, P.C. Omega-3 fatty acids and inflammatory processes: From molecules to man. Biochem. Soc. Trans. 2017, 45, 1105–1115. [Google Scholar] [CrossRef] [Green Version]
- Akbar, U.; Yang, M.; Kurian, D.; Mohan, C. Omega-3 Fatty Acids in Rheumatic Diseases: A Critical Review. J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 2017, 23, 330–339. [Google Scholar] [CrossRef]
- Kuda, O.; Rossmeisl, M.; Kopecky, J. Omega-3 fatty acids and adipose tissue biology. Mol. Asp. Med. 2018, 64, 147–160. [Google Scholar] [CrossRef]
- Ji, R.R.; Xu, Z.Z.; Strichartz, G.; Serhan, C.N. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 2011, 34, 599–609. [Google Scholar] [CrossRef]
- Zhang, L.Y.; Jia, M.R.; Sun, T. The roles of special pro-resolving mediators in pain relief. Rev. Neurosci. 2018, 29, 645–660. [Google Scholar] [CrossRef] [PubMed]
- Sun, G.Y.; Simonyi, A.; Fritsche, K.L.; Chuang, D.Y.; Hannink, M.; Gu, Z.; Greenlief, C.M.; Yao, J.K.; Lee, J.C.; Beversdorf, D.Q. Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins Leukot. Essent. Fat. Acids 2018, 136, 3–13. [Google Scholar] [CrossRef]
- Kumar Mp, S. The emerging role of serratiopeptidase in oral surgery: Literature update. Asian J. Pharm. Clin. Res. 2018, 11, 19–23. [Google Scholar] [CrossRef] [Green Version]
- Jadhav, S.B.; Shah, N.; Rathi, A.; Rathi, V.; Rathi, A. Serratiopeptidase: Insights into the therapeutic applications. Biotechnol. Rep. 2020, 28, e00544. [Google Scholar] [CrossRef] [PubMed]
- Moitra, S.; Sen, S.; Banerjee, I.; Das, P.; Tripathi, S.K. Diclofenac-serratiopeptidase combination induced stevens-johnson syndrome—A rare case report with review of literature. J. Clin. Diagn. Res. 2014, 8, YD08–YD11. [Google Scholar] [CrossRef]
- Rajaram, P.; Bhattacharjee, A.; Ticku, S. Serratiopeptidase—A Cause for Spread of Infection. J. Clin. Diagn. Res. 2016, 10, ZD31–ZD32. [Google Scholar] [CrossRef]
- Sivaramakrishnan, G.; Sridharan, K. Role of Serratiopeptidase After Surgical Removal of Impacted Molar: A Systematic Review and Meta-analysis. J. Maxillofac. Oral Surg. 2018, 17, 122–128. [Google Scholar] [CrossRef]
- Mali, N.; Wavikar, P.; Vavia, P. Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: In vitro and in vivo evaluation. AAPS PharmSciTech. 2015, 16, 59–66. [Google Scholar] [CrossRef] [Green Version]
- Hiking, P.; Bernasinska-Slomczewska, J. Beneficial Properties of Bromelain. Nutrients 2021, 13, 4313. [Google Scholar] [CrossRef]
- Bennour, I.; Haroun, N.; Sicard, F.; Mounien, L.; Landrier, J.F. Vitamin D and Obesity/Adiposity-A Brief Overview of Recent Studies. Nutrients 2022, 14, 2049. [Google Scholar] [CrossRef]
- Buesing, S.; Costa, M.; Schilling, J.M.; Moeller-Bertram, T. Vitamin B12 as a Treatment for Pain. Pain Physician 2019, 22, E45–E52. [Google Scholar] [CrossRef]
- Pavlov, C.S.; Damulin, I.V.; Shulpekova, Y.O.; Andreev, E.A. Neurological disorders in vitamin B12 deficiency. Ter. Arkhiv 2019, 91, 122–129. [Google Scholar] [CrossRef]
- Pfister, C.; Dawczynski, H.; Schingale, F.J. Selenium Deficiency in Lymphedema and Lipedema—A Retrospective Cross-Sectional Study from a Specialized Clinic. Nutrients 2020, 12, 1211. [Google Scholar] [CrossRef]
- Masullo, M.; Pizza, C.; Piacente, S. Ruscus Genus: A Rich Source of Bioactive Steroidal Saponins. Planta Med. 2016, 82, 1513–1524. [Google Scholar] [CrossRef] [Green Version]
- Woroń, J. Drugs containing extracts from Ruscus in chronic renal disease therapy—What’s new we know about their effects? Pol. Przegl. Chir. 2022, 94, 75–78. [Google Scholar] [CrossRef]
- Nourollahi, S.; Mondry, T.E.; Herbst, K.L. Bucher’s Broom and selenium improve lipedema: A retrospective case study. Altern. Integ. Med. 2013, 2, 2. [Google Scholar]
Supplement | Biochemical Action | Dosage | Suggestion |
---|---|---|---|
DHA and EPA | Anti-inflammatory Pain relieving | 1–2 g per day | Y |
Vitamin C | Antioxidant Support on collagen synthesis | 500–1000 mg per day | Y |
Polyphenols | Anti-inflammatory Antioxidant | 100–200 mg per day | E |
Vitamin D | Adipose tissue health Immunomodulation | 2000 IU per day | E |
Vitamin B12 | Pain relieving Neuropathy treatment | 500–1000 mcg | E |
Magnesium | General Health Muscle trophism Pain management | 300–400 mg per day | E |
Selenium | Immune system ROS scavenging | 45–60 mcg per day | E |
Serratiopeptidase | Oedema management Anti-inflammatory | 200–400 mg per day | N |
Bromelain | Oedema management | 300–600 mg per day | N |
Butcher’s Broom | Vessel trophism Lymphatic circulation | 150–300 mg per day | N |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cannataro, R.; Cione, E. Nutritional Supplements and Lipedema: Scientific and Rational Use. Nutraceuticals 2022, 2, 270-277. https://doi.org/10.3390/nutraceuticals2040020
Cannataro R, Cione E. Nutritional Supplements and Lipedema: Scientific and Rational Use. Nutraceuticals. 2022; 2(4):270-277. https://doi.org/10.3390/nutraceuticals2040020
Chicago/Turabian StyleCannataro, Roberto, and Erika Cione. 2022. "Nutritional Supplements and Lipedema: Scientific and Rational Use" Nutraceuticals 2, no. 4: 270-277. https://doi.org/10.3390/nutraceuticals2040020
APA StyleCannataro, R., & Cione, E. (2022). Nutritional Supplements and Lipedema: Scientific and Rational Use. Nutraceuticals, 2(4), 270-277. https://doi.org/10.3390/nutraceuticals2040020